Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
95
datasets available to search
ShareScore release 0.9.0
Dataset results
95 results for “Lymphoma cancer”
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants
ClinicalTrials.gov study NCT02737501. IPD Sharing: YES. Countries: 19. Publications: 5.
Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03410108. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib
ClinicalTrials.gov study NCT03535740. IPD Sharing: YES. Countries: 15. Publications: 3.
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
ClinicalTrials.gov study NCT02075840. IPD Sharing: Not stated. Countries: 29. Publications: 7.
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and C
ClinicalTrials.gov study NCT02604342. IPD Sharing: Not stated. Countries: 15. Publications: 2.
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01871805. IPD Sharing: Not stated. Countries: 2. Publications: 7.
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
ClinicalTrials.gov study NCT00932451. IPD Sharing: Not stated. Countries: 22. Publications: 7.
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
ClinicalTrials.gov study NCT02178475. IPD Sharing: Not stated. Countries: 9. Publications: 1.
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase
ClinicalTrials.gov study NCT00932893. IPD Sharing: Not stated. Countries: 22. Publications: 8.
A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04887519. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment
ClinicalTrials.gov study NCT01801111. IPD Sharing: Not stated. Countries: 16. Publications: 3.
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
ClinicalTrials.gov study NCT03888105. IPD Sharing: YES. Countries: 14. Publications: 3.
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05341583. IPD Sharing: NO. Countries: 1. Publications: 0.
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
ClinicalTrials.gov study NCT00323076. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
ClinicalTrials.gov study NCT02094573. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
ClinicalTrials.gov study NCT03984448. IPD Sharing: YES. Countries: 1. Publications: 1.
A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma Population
ClinicalTrials.gov study NCT05376709. IPD Sharing: NO. Countries: 1. Publications: 1.
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
ClinicalTrials.gov study NCT01382082. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation
ClinicalTrials.gov study NCT01637597. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship
ClinicalTrials.gov study NCT03260855. IPD Sharing: NO. Countries: 1. Publications: 10.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.